Shanell M.

Shanell M. has extensive work experience in the field of scientific research. Shanell is currently working as an Associate Scientist at Marengo Therapeutics since April 2023. Prior to this, they held the position of Senior Associate Scientist at Seismic Therapeutic from July 2022 to April 2023. Shanell also worked as a Senior Associate Scientist II at Scholar Rock from March 2022 to May 2022. Before that, Shanell was a Senior Associate Scientist at Codiak BioSciences from March 2021 to March 2022.

Their earlier experiences include working as an Associate Scientist II at Biogen from April 2018 to March 2021. In this role, they were involved in implementing small and large-scale production of monoclonal antibodies and recombinant protein from CHO cell lines. Shanell characterized antibodies through various techniques such as SDS-PAGE, size-exclusion chromatography, and binding assays. Additionally, they maintained cell lines and confirmed protein expression through western blotting.

Shanell's career began at Beth Israel Deaconess Medical Center, where they worked as a Research Assistant II from November 2015 to March 2018. In this role, they contributed to clinical trials by isolating NHP and human PBMCs, screening for cytokine response, and measuring antibody levels in human serum. Shanell also developed SOPs for GLP requirements and trained new personnel.

Furthermore, Shanell worked as a Research Technician I at Massachusetts General Hospital from April 2015 to October 2015.

Overall, Shanell M. has developed a strong background in scientific research through their various roles in different companies.

Shanell M. completed their education between 2010 and 2014 at Simmons University, where they earned a Bachelor of Science degree in Biochemistry.